Altimmune Overview
Company Headquarters: Maryland, US
Founded: 1997
Workforce: ~50
Company Working: Altimmune is a clinical-stage biopharmaceutical business focusing on treating obesity and liver illnesses. The business is working on HepTcell, an immunotherapeutic drug aimed at providing a functional cure for chronic hepatitis B. The company was formed through the merger of PharmAthene, Inc. ("PharmAthene") with the company formerly known as Altimmune
Strategy
At later phases of development, the company strategically partners with or out-licenses certain product candidates in order to focus its resources on early to mid-stage product development. To grow its pipeline, the company focuses on in-license or acquiring complementary metabolic or immunotherapeutic technologies and product candidates that are either synergistic or complementary to its capabilities. Design and develop treatments for obesity, NASH, and other metabolic illnesses using its EuPort platform technology.
